P&T Journal

P&T COMMUNITY

Our
Other
Journal

Join Us

About P&T Journal

Contacts:
Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com

Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints

Recent Issues

2013
- January
- February
- March
- April
- May
2012
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2011
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2010
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2009
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2008
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2007
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2006
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2005
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2004
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2003
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2002
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December

October 2010

Features

Personalized Medicine

Part 1: Evolution and Development into Theranostics

If clinicians know in advance which drugs will work for individual patients, they can eliminate trial-and-error prescribing, decrease costs, and improve outcomes. Part 1 of a three-part series reviews the history, barriers, and outlook of this emerging practice.
F. Randy Vogenberg, PhD, RPh; Carol Isaacson Barash, PhD; and Michael Pursel, RPh, MBA

Tacrolimus Interaction with Clotrimazole

A Concise Case Report and Literature Review

The case of a 23-year-old African-American woman who underwent live donor kidney transplantation illustrates the complexity of drug interactions involving the cytochrome P450 system.
Mary Choy, PharmD

Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States

Part 3: Policies and Practices Regarding Dietary Supplements In Health Care Facilities

Despite the increased acceptance of CAM and integrative medicine, many inpatient institutions have not established formal policies concerning their use. In the final article of this series, the challenges of integrating CAM (such as what to do about patients bringing dietary supplements into the hospital) are discussed.
C. Lee Ventola, MS

Pharmaceutical Approval Update

Topics include aliskiren/amlodipine (Tekamlo) tablets for hypertension, bimatoprost ophthamic solution (Lumigan 0.01%) for glaucoma, and hexaminolevulinate HCl (Cysview Solution) for the detection of bladder cancer.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

European Society of Cardiology

Selected sessions address antiplatelet therapies for acute coronary syndrome and cardiac and stroke risk reduction in patients with heart failure and atrial fibrillation.
Walter Alexander

Departments

Editorial

Davos Data and the World Economic Forum

The World Economic Forum has concluded that the only path to improved health is through disease prevention.
David B. Nash, MD, MBA

Medication Errors

The Five Rights

A Destination Without a Map

If we hold health care workers accountable for achieving the "five rights" of patient safety, we should give them the authority to design their own systems for achieving these outcomes.
Matthew Grissinger, RPh, FASCP

Prescription: Washington